5-羟基-2-(萘-1-基)苯甲醛 | 1030863-14-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 5-羟基-2-(萘-1-基)苯甲醛
• 英文名称: 5-hydroxy-2-(naphthalen-1-yl)benzaldehyde
• 英文别名: 5-Hydroxy-2-(naphthalen-1-yl)benzaldehyde；5-hydroxy-2-naphthalen-1-ylbenzaldehyde
• CAS: 1030863-14-9
• 化学式: C₁₇H₁₂O₂
• 分子量: 248.281
• InChiKey: WGEYTOGBOXQMCR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-羟基-2-(萘-1-基)苯甲醛 在 Ag[1-closo-CB11H6Cl6] 、 [PtCl₃(P(C₃(NMe₂)2)3)](perchlorate)2 、 potassium carbonate 作用下， 以 甲醇 、 1,2-二氯乙烷 为溶剂， 生成 苯并[g]菲-3-醇
  参考文献：
  名称：

  Exploiting the π-Acceptor Properties of Carbene-Stabilized Phosphorus Centered Trications [L₃P] ³⁺: Applications in Pt(II) Catalysis

  摘要：

  Reaction of tris(dimethylaminocyclopropenium) substituted phosphine 1 with K2PtCl4 afforded the bench stable complex 3 which upon treatment with Ag[CB11H6Cl6] turned out to be an excellent catalyst for the transformation of a variety of ortho-biaryl substituted alkynes into polycyclic homo- and heteroarenes of different size, shape, and curvature through a 6-endo-dig cyclization. This constitutes the first example ever reported of using a P-1-centered trication as ligand in catalysis. The strong pi-acceptor character of 1 that derives from its three positive charges substantially increases the intrinsic pi-acidity of Pt in complex 1.PtCl2 and dramatically enhances its ability to activate pi-systems toward nucleophilic attack. As a consequence, a remarkable acceleration of the model transformation is observed when compared with other classical pi-acceptor ligands such as P(OPh)(3) or P(C6F5)(3). Moreover, the employment of 1 as ligand also expands the scope of this reaction to previously inaccessible substitution patterns. Kinetic studies and deuterium labeling experiments as well as density functional theory (DFT) calculations were performed in order to explain these findings.

  DOI：

  10.1021/ja306947m
• 作为产物：
  描述：

  2-溴-5-羟基苯甲醛 、 1-萘硼酸 在 palladium diacetate sodium carbonate 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 以74%的产率得到5-羟基-2-(萘-1-基)苯甲醛
  参考文献：
  名称：

  NOVEL CURCUMIN DERIVATIVE

  摘要：

  为了开发一种高度安全的措施来治疗阿尔茨海默病，提供了一种由以下一般式（I）或其盐表示的化合物： 其中A代表苯基或类似物，R1代表氯原子、溴原子或硝基团等，R2、R3、R4和R5各自代表氢原子或类似物，L代表CH2—CH2或CH═CH。

  公开号：

  US20110082295A1

文献信息

• Therapeutic agent for Alzheimer's disease
  申请人：Sugimoto Hachiro

  公开号：US08552220B2

  公开（公告）日：2013-10-08

  To develop a highly safe measure to treat Alzheimer's disease using a secretase-inhibiting substance, there is provided a compound represented by the following general formula (I) or a salt thereof: wherein A represents a phenyl group or the like, R1 represents a chlorine atom, a bromine atom, or a nitro group or the like, R2, R3, R4, and R5 each represent a hydrogen atom or the like, and L represents CH2—CH2 or CH═CH.

  为了开发一种高度安全的措施来治疗阿尔茨海默病，使用一种分泌酶抑制物质，提供一种由以下通式（I）表示的化合物或其盐：其中，A代表苯基或类似物，R1代表氯原子、溴原子或硝基基团或类似物，R2、R3、R4和R5各代表氢原子或类似物，L代表CH2- 或CH═CH。
• Curcumin derivative
  申请人：Takahashi Takashi

  公开号：US08962674B2

  公开（公告）日：2015-02-24

  The present invention provides a novel compound that is structurally similar to curcumin and has a suppressive effect on Aβ aggregation, a degradative effect on Aβ aggregates, an inhibitory effect on β-secretase, and a protective effect on neurons. The novel compound is a compound represented by the following general formula (Ia) or a salt thereof: wherein R1 represents a 4-hydroxy-3-methoxyphenyl group or the like, and R2 represents a 1H-indol-6-yl group or the like.

  本发明提供了一种新型化合物，其结构类似于姜黄素，并具有抑制Aβ聚集、降解Aβ聚集物、抑制β-分泌酶和保护神经元的作用。该新型化合物是由以下一般式(Ia)表示的化合物或其盐：其中R1代表4-羟基-3-甲氧基苯基或类似物，R2代表1H-吲哚-6-基基或类似物。
• THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE
  申请人：Tokyo Institute of Technology

  公开号：EP2305629A1

  公开（公告）日：2011-04-06

  To develop a highly safe measure to treat Alzheimer's disease using a secretase-inhibiting substance, there is provided a compound represented by the following general formula (I) or a salt thereof: wherein A represents a phenyl group or the like, R1 represents a chlorine atom, a bromine atom, or a nitro group or the like, R2, R3, R4, and R5 each represent a hydrogen atom or the like, and L represents CH2-CH2 or CH=CH.

  为了开发一种使用分泌酶抑制物质治疗阿尔茨海默病的高度安全的措施，提供了由下式通式（I）代表的化合物或其盐： 其中 A 代表苯基或类似物，R1 代表氯原子、溴原子或硝基或类似物，R2、R3、R4 和 R5 各代表氢原子或类似物，L 代表 CH2- 或 CH=CH。
• US8552220B2
  申请人：——

  公开号：US8552220B2

  公开（公告）日：2013-10-08
• US8962674B2
  申请人：——

  公开号：US8962674B2

  公开（公告）日：2015-02-24